Phenotypic and molecular analysis of six human cell lines derived from patients with plasma cell dyscrasia

被引:35
作者
Gooding, RP
Bybee, A
Cooke, F
Little, A
Marsh, SGE
Coelho, E
Gupta, D
Samson, D
Apperley, JF
机构
[1] Hammersmith Hosp, Myeloma Unit, Dept Haematol, Imperial Coll,Sch Med, London W12 0NN, England
[2] Anthony Nolan Bone Marrow Trust, Tissue Typing Lab, London, England
关键词
myeloma; cell line; characterization; cytokine; PCR;
D O I
10.1046/j.1365-2141.1999.01602.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cell lines RPMI 8226, JJN3. U266 B1, NCI-H929 tall EBV-) and ARH77 and HS-Sultan (both EBV+) have been extensively characterized in this study, EBV- lines expressed the phenotype (CD138(-), CD19(+), CD20(+)) whereas EBV+ were (CD138(+), CD19(-), CD20(-)). CD56 expression was restricted to EBV- cell lines, with the exception of U266 B1, whereas PCA-1 was strongly expressed on five of the six cell lines. Only EBV+ cell lines bound peanut-agglutinin (PNA). However, all cell lines bound the lectin Jacalin that binds the same receptor as PNA, irrespective of the receptors sialylation status. By RT-PCR and direct sequencing of their IgH V/D/J domains, ARH77 was demonstrated to use the germline sequence VH4-34/dm1/JH6b, whereas no arrangement was demonstrated for RPMI 8226, suggesting IgH gene deletion or mutation, HLA class I and II antigens were detected using HLA typing on all cell lines warranting their use as suitable targets for HLA-restricted cytotoxic T cells. By sensitive RT-PCR, mRNA for IL-6, IL6R and TNF beta was found expressed in all cell lines. IL-1 mRNA expression was predominantly associated with the EBV+ phenotype. Although mRNA for IL-3 and GM-CSF was never detected, transcripts for c-kit Ligand and, more commonly, its receptor were. Likewise GM-CSF, M-CSF and erythropoietin mRNA transcripts were detected in the majority of cell lines.
引用
收藏
页码:669 / 681
页数:13
相关论文
共 59 条
[1]  
ANDERSON KC, 1983, J IMMUNOL, V130, P1132
[2]  
AUBIN J, 1995, LEUKEMIA, V9, P471
[3]   ROLE OF INTERLEUKIN-6 IN THE GROWTH OF MYELOMA-DERIVED CELL-LINES [J].
BARUT, BA ;
ZON, LI ;
COCHRAN, MK ;
PAUL, SR ;
CHAUHAN, D ;
MOHRBACHER, A ;
FINGEROTH, J ;
ANDERSON, KC .
LEUKEMIA RESEARCH, 1992, 16 (10) :951-959
[4]  
BORSET M, 1993, BRIT J HAEMATOL, V85, P446
[5]  
BURK KH, 1978, CANCER RES, V38, P2508
[6]   Tracking of the V-4-34 (V(H)4-21) gene in human tonsil reveals clonal isotype switch events and a highly variable degree of somatic hypermutation [J].
Chapman, CJ ;
Mockridge, CI ;
Hamblin, TJ ;
Stevenson, FK .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 105 (02) :360-368
[7]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[8]   CONSTITUTIVE IN-VIVO CYTOKINE AND HEMATOPOIETIC GROWTH-FACTOR GENE-EXPRESSION IN THE BONE-MARROW AND PERIPHERAL-BLOOD OF HEALTHY-INDIVIDUALS [J].
CLUITMANS, FHM ;
ESENDAM, BHJ ;
LANDEGENT, JE ;
WILLEMZE, R ;
FALKENBURG, JHF .
BLOOD, 1995, 85 (08) :2038-2044
[9]   Interleukin-1 in multiple myeloma: producer cells and their role in the control of IL-6 production [J].
Costes, V ;
Portier, M ;
Lu, ZY ;
Rossi, JF ;
Bataille, R ;
Klein, B .
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (04) :1152-1160
[10]  
COZZOLINO F, 1989, BLOOD, V74, P380